Navigation
Home
Advocating for Access
Background
Letters for Access
Press Releases For Access
Simplified Community Materials
Simplified Community Materials
Understanding your HCV infection
Community Led Reports
Country Information
Indonesia
India
Vietnam
Generic DAAs Pricing
Resources
Guidelines
Key Research Publication
Other Important Documents and Reports
News
Gallery
Photos
Video
Stories
Simplified HCV Treatment* for Treatment-Naive Patients Without Cirrhosis
Simplified HCV Treatment* for Treatment-Naive Patients Without Cirrhosis
Download (PDF, 222KB)
December 3, 2019
/
Guidelines
,
News
Share
the Post
Related
Posts
Four Indian generic companies take sub license from MPP on daclatasvir
Patent Situation of The Key Product For Treatment of Hepatitis C: SOFOSBUVIR – WHO working paper, updated 2015
Availability and Pricing of Generic Sofosbuvir in India – Updated 10 September 2015
Pricing of Indian generic sofosbuvir, 30th Jan,2016
Fact Sheet Hepatitis B
Know the interactions between HIV and Hep C medicines
Generic daclatasvir (60 mg) availability and India market pricing as of 30 January 2016
Read More
Story from Ayu Oktariani, Bandung, Indonesia
